Table A2.
Subgroup analysis: ES and SRM of delta 1 and delta 2 in patients without chemotherapy.
| HRQoL | SRM: Delta 1 | SRM: Delta 2 | ES: Delta 1 | ES: Delta 2 |
|---|---|---|---|---|
| EQ-5D-5L | ||||
| Index | −0.350 | −0.200 | −0.365 | −0.269 |
| VAS score | −0.182 | −0.138 | −0.208 | −0.168 |
| EORTC QLQ-C30 | ||||
| Global Quality of Life scale | −0.032 | −0.048 | −0.033 | −0.059 |
| Physical functioning | −0.351 | −0.307 | −0.341 | −0.258 |
| Role functioning | −0.276 | −0.203 | −0.343 | −0.247 |
| Emotional functioning | 0.236 | 0.360 | 0.262 | 0.409 |
| Cognitive functioning | −0.315 | −0.181 | −0.400 | −0.239 |
| Social functioning | −0.258 | −0.133 | −0.304 | −0.169 |
| Fatigue | 0.334 | 0.154 | 0.401 | 0.167 |
| Nausea and vomiting | 0.006 | −0.067 | 0.008 | −0.078 |
| Pain | 0.253 | 0.278 | 0.313 | 0.339 |
| Dyspnea | 0.253 | 0.252 | 0.312 | 0.269 |
| Insomnia | 0.044 | −0.017 | 0.050 | −0.019 |
| Appetite loss | −0.040 | −0.193 | −0.041 | −0.194 |
| Constipation | 0.101 | 0.079 | 0.148 | 0.091 |
| Diarrhea | −0.045 | −0.034 | −0.051 | −0.038 |
| Financial difficulties | 0.140 | 0.063 | 0.165 | 0.083 |
| Summary score | −0.283 | −0.124 | −0.318 | −0.145 |
Abbreviations: SRM, standardized response mean; ES, effect size. Note: delta 1, difference in scores between T0 and T6; delta 2, difference in scores between T0 and T12.